Eir Therapeutics

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 5, 2024	Lykos Therapeutics	$100.0M Series A	Suprotik Basu	Bail Capital, KittyHawk Ventures, Satori Neuro, Alexandra M. Cohen, The Joe and Sandy Samberg Foundation, True Ventures, Unlikely Collaborators, Vine Ventures

Total Raised

N/A

Valuation

N/A